Six years after a blockbuster $40 million funder, Morrisville-based TearScience is at it again, raising a new $19.3 million in equity financing.
New CEO Joe Boorady calls the cash a “great sign of confidence in the organization.” And he says it’s a sign that the changes he’s helping institute are working.
Read: Management shakeup at TearScience
In the 13 months since he took over the CEO seat at the dry eye-focused ophthalmic device maker, a strategic shift and a new price point have contributed…
Six years after a blockbuster $40 million funder, Morrisville-based TearScience is at it again, raising a new $19.3 million in equity financing.
New CEO Joe Boorady calls the cash a “great sign of confidence in the organization.” And he says it’s a sign that the changes he’s helping institute are working.
Read: Management shakeup at TearScience
In the 13 months since he took over the CEO seat at the dry eye-focused ophthalmic device maker, a strategic shift and a new price point have contributed…